Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Duncavage

Showing results (11-20 of 117) with videos related to

Pageof 12
Sort By:
Human Pathology|November 8, 2013
MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumorsKatherine E Schwetye, John D Pfeifer, Eric J Duncavage
The Journal of Molecular Diagnostics : JMD|November 19, 2016
In Silico Proficiency Testing for Clinical Next-Generation SequencingEric J Duncavage, Haley J Abel, John D Pfeifer
Experimental and Molecular Pathology|June 3, 2014
Copy number variants in clinical next-generation sequencing data can define the relationship between simultaneous tumors in an individual patientJennifer K Sehn, Haley J Abel, Eric J Duncavage
Experimental and Molecular Pathology|October 3, 2012
Detection of Merkel cell polyomavirus in chronic lymphocytic leukemia T-cellsPatrick J Cimino, David W Bahler, Eric J Duncavage
Trends in Cancer|July 26, 2017
Implications of Tumor Clonal Heterogeneity in the Era of Next-Generation SequencingMeagan A Jacoby, Eric J Duncavage, Matthew J Walter
Cancer Cytopathology|November 15, 2013
Targeted next-generation sequencing using fine-needle aspirates from adenocarcinomas of the lungHope E Karnes, Eric J Duncavage, Cory T Bernadt
Frontiers in Cell and Developmental Biology|May 28, 2020
Sequencing-Based Measurable Residual Disease Testing in Acute Myeloid LeukemiaJennifer M Yoest, Cara Lunn Shirai, Eric J Duncavage
The American Journal of Surgical Pathology|October 8, 2009
Merkel cell polyomavirus: a specific marker for Merkel cell carcinoma in histologically similar tumorsEric J Duncavage, Binh-Minh Le, David Wang, et al.
Experimental and Molecular Pathology|April 26, 2015
A wide spectrum of EGFR mutations in glioblastoma is detected by a single clinical oncology targeted next-generation sequencing panelPatrick J Cimino, Andy Bredemeyer, Haley J Abel, et al.
Haematologica|February 23, 2019
TP53 immunohistochemistry correlates with <i>TP53</i> mutation status and clearance in decitabine-treated patients with myeloid malignanciesMarianna B Ruzinova, Yi-Shan Lee, Eric J Duncavage, et al.
Pageof 12

Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
Human Pathology|November 8, 2013
MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumorsKatherine E Schwetye, John D Pfeifer, Eric J Duncavage
The Journal of Molecular Diagnostics : JMD|November 19, 2016
In Silico Proficiency Testing for Clinical Next-Generation SequencingEric J Duncavage, Haley J Abel, John D Pfeifer
Experimental and Molecular Pathology|June 3, 2014
Copy number variants in clinical next-generation sequencing data can define the relationship between simultaneous tumors in an individual patientJennifer K Sehn, Haley J Abel, Eric J Duncavage
Experimental and Molecular Pathology|October 3, 2012
Detection of Merkel cell polyomavirus in chronic lymphocytic leukemia T-cellsPatrick J Cimino, David W Bahler, Eric J Duncavage
Trends in Cancer|July 26, 2017
Implications of Tumor Clonal Heterogeneity in the Era of Next-Generation SequencingMeagan A Jacoby, Eric J Duncavage, Matthew J Walter
Cancer Cytopathology|November 15, 2013
Targeted next-generation sequencing using fine-needle aspirates from adenocarcinomas of the lungHope E Karnes, Eric J Duncavage, Cory T Bernadt
Frontiers in Cell and Developmental Biology|May 28, 2020
Sequencing-Based Measurable Residual Disease Testing in Acute Myeloid LeukemiaJennifer M Yoest, Cara Lunn Shirai, Eric J Duncavage
The American Journal of Surgical Pathology|October 8, 2009
Merkel cell polyomavirus: a specific marker for Merkel cell carcinoma in histologically similar tumorsEric J Duncavage, Binh-Minh Le, David Wang, et al.
Experimental and Molecular Pathology|April 26, 2015
A wide spectrum of EGFR mutations in glioblastoma is detected by a single clinical oncology targeted next-generation sequencing panelPatrick J Cimino, Andy Bredemeyer, Haley J Abel, et al.
Haematologica|February 23, 2019
TP53 immunohistochemistry correlates with <i>TP53</i> mutation status and clearance in decitabine-treated patients with myeloid malignanciesMarianna B Ruzinova, Yi-Shan Lee, Eric J Duncavage, et al.
Pageof 12